Currently out of the existing stock ratings of Chad Mabry, 36 are a BUY (97.3%), 1 are a HOLD (2.7%).

Chad Mabry

Work Performance Price Targets & Ratings Chart

Analyst Chad Mabry, carries an average stock price target met ratio of 38.33% that have a potential upside of 15.91% achieved within 331 days. Previously, Chad Mabry worked at MLV.

Chad Mabry’s has documented 71 price targets and ratings displayed on 10 stocks. The coverage was on Energy, Healthcare sectors.

Most recent stock forecast was given on MNOV, MediciNova at 16-Jun-2025.

Wall Street Analyst Chad Mabry

Analyst best performing recommendations are on ESTE (EARTHSTONE ENERGY).
The best stock recommendation documented was for ESTE (EARTHSTONE ENERGY) at 5/11/2016. The price target of $15 was fulfilled within 14 days with a profit of $3.43 (29.65%) receiving and performance score of 21.18.

Average potential price target upside

CPE Callon Petroleum Company CRZO Carrizo Oil & Gas ESTE Earthstone Energy GTBP GT Biopharma INMB INmune Bio ALT Altimmune MTDR Matador Resources Company QEP QEP Resources WPX WPX Energy MNOV MediciNova

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

Since 03-Jan-2024

$38

$2.24 (6.26%)

$40

1 years 10 months 27 days ago
(26-Feb-2024)

1/11 (9.09%)

$7.17 (23.26%)

7

Hold

Since 23-Jan-2024

$32

$-3.76 (-10.51%)

$44

1 years 11 months 30 days ago
(23-Jan-2024)

1/10 (10%)

$0.42 (1.33%)

1

Buy

Since 21-Apr-2022

$45

$9.24 (25.84%)

$51

2 years 14 days ago
(08-Jan-2024)

7/22 (31.82%)

$10.47 (30.32%)

43

Hold

Since 19-Apr-2023

$40

$4.24 (11.86%)

$41

2 years 1 months 24 days ago
(29-Nov-2023)

1/4 (25%)

$8.43 (26.70%)

45

Since 22-Apr-2022

$40

$4.24 (11.86%)

$41

2 years 1 months 24 days ago
(29-Nov-2023)

5/14 (35.71%)

$8.43 (26.70%)

30

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Chad Mabry?

On 2014

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?